Mepivacaine
Indications
Registered South African indications:
- Local anaesthesia
Cautions
Contraindications
- Known hypersensitivity to the amide type of local anaesthetic or excipients
- Children below 4 years of age (ca. 20 kg body weight)
- Porphyria
- Severe disorders of the atrioventricular conduction not compensated by pacemaker
- Epilepsy not controlled by appropriate treatment
Cautions
- Pregnancy
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Elderly
- Cardiovascular disease
- Hyperthyroidism
- Acutely ill patients
- Debilitated patients
- Intravenous administration
Adult dosage
Forms avail. in SA and covered in this monograph: inj
Local anaesthesia - oral region
- SC: Max: Up to 400mg/dose; Max: 1g/24hrs
Dosage depends on the site to be anaesthetised, the area and vascularity thereof, condition of patient, duration of anaesthesia required and the technique used
Paediatric dosage
Contraindicated in children below 4 years
Special populations
Pregnancy
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
- Contraindicated
Adverse reactions
Central Nervous System Disorders
- Yawning
- Restlessness
- Excitement
- Nervousness
- Dizziness
- Tinnitus
- Nystagmus
- Muscle twitching
- Tremors
- Seizures
- Drowsiness
- Coma
- Anxiety
- Chills
- Confusion
- Increased body temperature
- Paralysis
- Persistent anaesthesia
Cardiovascular Disorders
- Myocardial depression
- Peripheral vasodilation
- Hypotension
- Bradycardia
- Arrhythmias
- Cardiac arrest
- Cardiac insufficiency
- Cardiovascular depression
- Cardiovascular stimulation
- Heart block
- Hypertension
- Low cardiac output
- Syncope
- Tachycardia
Respiratory Disorders
- Respiratory failure
- Apnoea
- Respiratory depression
- Sneezing
Gastrointestinal Disorders
- Nausea and vomiting
- Fecal incontinence
- Oral paresthesia
Genitourinary Disorders
- Urinary incontinence
- Urinary retention
Musculoskeletal Disorders
- Chondrolysis
- Tremor
- Weakness
Skin and Subcutaneous Tissue Disorders
- Diaphoresis
- Erythema
- Pruritus
- Urticaria
Immune, Blood and Lymphatic System Disorders
- Methaemoglobinaemia
- Anaphylactoid reaction
- Angioedema
- Hypersensitivity reaction
Sensory Disorders
- Blurred vision
- Miosis
- Tinnitis
Interactions
Bupivacaine
Monitoring
None routine
Mechanism of action
Mepivacaine is a local anaesthetic of the amide type. It has a rapid onset and intermediate duration of action. Local anesthetics bind selectively to the intracellular surface of sodium channels to block influx of sodium into the axon. As a result, depolarization necessary for action potential propagation and subsequent nerve function is prevented.
Dosage forms
- Injection
Formulation
Injection (per 1.8ml) 54mg
- Carbocaine 3% Dental (Adcock) originator
- Scandonest 3% Plain (The Dental Warehouse)
References
1. SAMF_12th Edition_Page 433 2. PI: Scandonest 3% solution for Injections, The Dental Warehouse (Pty) Ltd:Date of registration: 8 Oct 1991[https://drive.google.com/drive/u/0/folders/1Fucdt43z2R_BaUQsDPZWZSslLdwevA3r] 3. PI: Carbocaine 3% Dental Injections, Adcock Ingram Ltd:Date of registration: 18 Aug 1988 [https://drive.google.com/drive/u/0/folders/1Fucdt43z2R_BaUQsDPZWZSslLdwevA3r] 4. Drugs.com: Mepivacaine; Downloaded online 23 Nov 2018 [https://drive.google.com/drive/u/0/folders/1Fucdt43z2R_BaUQsDPZWZSslLdwevA3r] 5. https://www.uptodate.com/contents/mepivacaine-drug-information?source=search_result&search=mepivacaine&selectedTitle=1~28 6. PI - CARBOCAINE 3 % DENTAL, Adcock Ingram Limited - DATE OF REVISION OF THE TEXT 02 May 2022 - Downloaded online 04 Oct 2024 [https://pi-pil-repository.sahpra.org.za/wp-content/uploads/2022/05/approved-PI.pdf] **No SPC available
Brands & products
4 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days oldinjectionGeneric· 4 products
from R13.49/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Carbocaine 1.8ml | 54 mg/1.8ml | 1 | S4 | R1348.82 | R13.49 | R282.90 | 712515003 |
| Carbocaine l 1.8ml | - mg/1.8ml | 1 | S4 | R1348.82 | R13.49 | R282.90 | 712485007 |
| Scandonest cartridge 1.8ml | 36 mg | 1 | S4 | R702.21 | R14.04 | R187.77 | 857319019 |
| Scandonest cartridge 1.8ml | 54 mg | 1 | S4 | R703.80 | R14.08 | R188.00 | 817627006 |
- Carbocaine 3% Dental
- Scandonest 3% Plain
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.